Michael Hasenson

452 citations
7 papers · 390 indexed · h-index 6

Michael Hasenson

7 papers receiving 373 citations

Peers

Michael Hasenson
Comparison fields: 5 of 101
  • Pulmonary and Respiratory Medicine 144
  • Endocrinology, Diabetes and Metabolism 45
  • Rheumatology 40
  • Cancer Research 36
  • Molecular Biology 158
Replace S D Mikolajczyk with:
S D Mikolajczyk United States
Uk-Il Kim
Diego Martínez-López Spain
Barry Lesser Canada
Hajime Yamamoto Japan
Coffey Ds United States
H Yamanishi Japan
Kaoru Otsu Japan
Xu Shi China
Eleonora Scarlata Canada
Michael Hasenson relative to S D Mikolajczyk United States S D Mikolajczyk's profile →
Citations per field
00.5×1.5×
S D Mikolajczyk · 1×
Citations per year

Countries citing papers authored by Michael Hasenson

Since Specialization
Citations

This map shows the geographic impact of Michael Hasenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hasenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hasenson more than expected).

Fields of papers citing papers by Michael Hasenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hasenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hasenson. The network helps show where Michael Hasenson may publish in the future.

Co-authorship network

The 13 scholars most cited alongside Michael Hasenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hasenson Line = papers co-authored together Michael Hasenson links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 199227
2 199028
3 198933
4 19894
5 198942
6 1986201
7 198555

About Michael Hasenson

Michael Hasenson is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Genetics, Spectroscopy and Endocrinology, Diabetes and Metabolism, having authored 7 papers that have together received 390 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Estrogen and related hormone effects (2 papers), Hormonal and reproductive studies (1 paper), Mitochondrial Function and Pathology (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Adipose Tissue and Metabolism (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (144 citations), Endocrinology, Diabetes and Metabolism (45 citations), Rheumatology (40 citations), Cancer Research (36 citations) and Molecular Biology (158 citations). Michael Hasenson has collaborated with scholars based in Sweden, Netherlands and United States. Frequent co-authors include Åke Pousette, Arne Lundin, Jörgen Persson, B. Lundh, Reinhard Stege, Kjell Carlström, Beryl Hartley‐Asp, Jan-Ακε Gustafsson, Bernhard Tribukait and G.J. van Steenbrugge. Their work appears in journals such as The Prostate, The Journal of Urology, Methods in enzymology on CD-ROM/Methods in enzymology and Urological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026